147 related articles for article (PubMed ID: 27878865)
1. Fibroblast growth factor 21 night watch: advances and uncertainties in the field.
Kharitonenkov A; DiMarchi R
J Intern Med; 2017 Mar; 281(3):233-246. PubMed ID: 27878865
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
[TBL] [Abstract][Full Text] [Related]
3. BetaKlotho is required for metabolic activity of fibroblast growth factor 21.
Ogawa Y; Kurosu H; Yamamoto M; Nandi A; Rosenblatt KP; Goetz R; Eliseenkova AV; Mohammadi M; Kuro-o M
Proc Natl Acad Sci U S A; 2007 May; 104(18):7432-7. PubMed ID: 17452648
[TBL] [Abstract][Full Text] [Related]
4. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.
Suzuki M; Uehara Y; Motomura-Matsuzaka K; Oki J; Koyama Y; Kimura M; Asada M; Komi-Kuramochi A; Oka S; Imamura T
Mol Endocrinol; 2008 Apr; 22(4):1006-14. PubMed ID: 18187602
[TBL] [Abstract][Full Text] [Related]
5. Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19).
Wu X; Ge H; Lemon B; Vonderfecht S; Baribault H; Weiszmann J; Gupte J; Gardner J; Lindberg R; Wang Z; Li Y
Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14158-63. PubMed ID: 20660733
[TBL] [Abstract][Full Text] [Related]
6. Regulation and Potential Biological Role of Fibroblast Growth Factor 21 in Chronic Kidney Disease.
Zhou X; Zhang Y; Wang N
Front Physiol; 2021; 12():764503. PubMed ID: 34675822
[TBL] [Abstract][Full Text] [Related]
7. FGF21 and metabolic disease in 2016: A new frontier in FGF21 biology.
Potthoff MJ
Nat Rev Endocrinol; 2017 Feb; 13(2):74-76. PubMed ID: 27983736
[No Abstract] [Full Text] [Related]
8. Fibroblast Growth Factor 21 (FGF21) Promotes Formation of Aerobic Myofibers via the FGF21-SIRT1-AMPK-PGC1α Pathway.
Liu X; Wang Y; Hou L; Xiong Y; Zhao S
J Cell Physiol; 2017 Jul; 232(7):1893-1906. PubMed ID: 27966786
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Ketone Body Metabolism and the Role of PPARα.
Grabacka M; Pierzchalska M; Dean M; Reiss K
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27983603
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 21 and its novel association with oxidative stress.
Gómez-Sámano MÁ; Grajales-Gómez M; Zuarth-Vázquez JM; Navarro-Flores MF; Martínez-Saavedra M; Juárez-León ÓA; Morales-García MG; Enríquez-Estrada VM; Gómez-Pérez FJ; Cuevas-Ramos D
Redox Biol; 2017 Apr; 11():335-341. PubMed ID: 28039838
[TBL] [Abstract][Full Text] [Related]
11. The role of fibroblast growth factor 21 in atherosclerosis.
Kokkinos J; Tang S; Rye KA; Ong KL
Atherosclerosis; 2017 Feb; 257():259-265. PubMed ID: 28012645
[TBL] [Abstract][Full Text] [Related]
12. Novel functions of circulating Klotho.
Hum JM; O'Bryan L; Smith RC; White KE
Bone; 2017 Jul; 100():36-40. PubMed ID: 27890549
[TBL] [Abstract][Full Text] [Related]
13. Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases.
Ji X; Zhao L; Ji K; Zhao Y; Li W; Zhang R; Hou Y; Lu J; Yan C
Mol Neurobiol; 2017 Dec; 54(10):8110-8116. PubMed ID: 27889897
[TBL] [Abstract][Full Text] [Related]
14. Anti-human fibroblast growth factor-21 monoclonal antibody preparation, characterization and analysis of
Ding L; Hao Z; Yuan Q; Xu P; Yu Y; Li D
Exp Ther Med; 2016 Nov; 12(5):3417-3424. PubMed ID: 27882173
[TBL] [Abstract][Full Text] [Related]
15. Relationship between FGF21 and UCP1 levels under time-restricted feeding and high-fat diet.
Chapnik N; Genzer Y; Froy O
J Nutr Biochem; 2017 Feb; 40():116-121. PubMed ID: 27883936
[TBL] [Abstract][Full Text] [Related]
16. Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 Action.
Zhang J; Gupte J; Gong Y; Weiszmann J; Zhang Y; Lee KJ; Richards WG; Li Y
EBioMedicine; 2017 Feb; 15():173-183. PubMed ID: 28041926
[TBL] [Abstract][Full Text] [Related]
17. KLB is associated with alcohol drinking, and its gene product β-Klotho is necessary for FGF21 regulation of alcohol preference.
Schumann G; Liu C; O'Reilly P; Gao H; Song P; Xu B; Ruggeri B; Amin N; Jia T; Preis S; Segura Lepe M; Akira S; Barbieri C; Baumeister S; Cauchi S; Clarke TK; Enroth S; Fischer K; Hällfors J; Harris SE; Hieber S; Hofer E; Hottenga JJ; Johansson Å; Joshi PK; Kaartinen N; Laitinen J; Lemaitre R; Loukola A; Luan J; Lyytikäinen LP; Mangino M; Manichaikul A; Mbarek H; Milaneschi Y; Moayyeri A; Mukamal K; Nelson C; Nettleton J; Partinen E; Rawal R; Robino A; Rose L; Sala C; Satoh T; Schmidt R; Schraut K; Scott R; Smith AV; Starr JM; Teumer A; Trompet S; Uitterlinden AG; Venturini C; Vergnaud AC; Verweij N; Vitart V; Vuckovic D; Wedenoja J; Yengo L; Yu B; Zhang W; Zhao JH; Boomsma DI; Chambers J; Chasman DI; Daniela T; de Geus E; Deary I; Eriksson JG; Esko T; Eulenburg V; Franco OH; Froguel P; Gieger C; Grabe HJ; Gudnason V; Gyllensten U; Harris TB; Hartikainen AL; Heath AC; Hocking L; Hofman A; Huth C; Jarvelin MR; Jukema JW; Kaprio J; Kooner JS; Kutalik Z; Lahti J; Langenberg C; Lehtimäki T; Liu Y; Madden PA; Martin N; Morrison A; Penninx B; Pirastu N; Psaty B; Raitakari O; Ridker P; Rose R; Rotter JI; Samani NJ; Schmidt H; Spector TD; Stott D; Strachan D; Tzoulaki I; van der Harst P; van Duijn CM; Marques-Vidal P; Vollenweider P; Wareham NJ; Whitfield JB; Wilson J; Wolffenbuttel B; Bakalkin G; Evangelou E; Liu Y; Rice KM; Desrivières S; Kliewer SA; Mangelsdorf DJ; Müller CP; Levy D; Elliott P
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14372-14377. PubMed ID: 27911795
[TBL] [Abstract][Full Text] [Related]
18. An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial function.
Lee JH; Kang YE; Chang JY; Park KC; Kim HW; Kim JT; Kim HJ; Yi HS; Shong M; Chung HK; Kim KS
Am J Transl Res; 2016; 8(11):4750-4763. PubMed ID: 27904677
[TBL] [Abstract][Full Text] [Related]
19. Treatment with FGFR2-IIIc monoclonal antibody suppresses weight gain and adiposity in KKA
Nonogaki K; Kaji T; Yamazaki T; Murakami M
Nutr Diabetes; 2016 Nov; 6(11):e233. PubMed ID: 27892934
[TBL] [Abstract][Full Text] [Related]
20. FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases.
Sonoda J; Chen MZ; Baruch A
Horm Mol Biol Clin Investig; 2017 May; 30(2):. PubMed ID: 28525362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
